Characterization of SARS-CoV-2 Aerosols Dispersed During Noninvasive Respiratory Support of Patients With COVID-19

REFERENCES

1. 1.↵
   1. Meyerowitz EA,
   2. Richterman A,
   3. Gandhi RT,
   4. Sax PE

   . Transmission of SARS-CoV-2: a review of viral, host, and environmental factors. Ann Intern Med 2021;174(1):69-79.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Lednicky JA,
   2. Lauzard M,
   3. Fan ZH,
   4. Jutla A,
   5. Tilly TB,
   6. Gangwar M,
   7. et al

   . Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int J Infect Dis 2020;100:476-482.

   OpenUrlCrossRefPubMed
3. 3.
   1. Santarpia JL,
   2. Rivera DN,
   3. Herrera VL,
   4. Morwitzer MJ,
   5. Creager HM,
   6. Santarpia GW,
   7. et al

   . Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care. Sci Rep 2020;10(1):12732.

   OpenUrlCrossRefPubMed
4. 4.
   1. Chia PY,
   2. Coleman KK,
   3. Tan YK,
   4. Ong SWX,
   5. Gum M,
   6. Lau SK,
   7. et al

   ; Singapore 2019 Novel Coronavirus Outbreak Research Team. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat Commun 2020;11(1):2800.

   OpenUrlCrossRefPubMed
5. 5.
   1. Liu Y,
   2. Ning Z,
   3. Chen Y,
   4. Guo M,
   5. Liu Y,
   6. Gali NK,
   7. et al

   . Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature 2020;582(7813):557-560.

   OpenUrlCrossRefPubMed
6. 6.
   1. Guo ZD,
   2. Wang ZY,
   3. Zhang SF,
   4. Li X,
   5. Li L,
   6. Li C,
   7. et al

   . Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis 2020;26(7):1583-1591.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Habibi N,
   2. Uddin S,
   3. Behbehani M,
   4. Abdul Razzack N,
   5. Zakir F,
   6. Shajan A

   . SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing. Infect Prev Pract 2022;4(1):100199.

   OpenUrl
8. 8.↵
   1. Tobin MJ,
   2. Laghi F,
   3. Jubran A

   . Caution about early intubation and mechanical ventilation in COVID-19. Ann Intensive Care 2020;10(1):78.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Li J,
   2. Alolaiwat A,
   3. Fink JB,
   4. Dhand R

   . Aerosol-generating procedures and virus transmission. Respir Care 2022;67(8):1022-1042. [Epub ahead of print]

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Hui DS,
    2. Chow BK,
    3. Lo T,
    4. Tsang OTY,
    5. Ko FW,
    6. Ng SS,
    7. et al

    . Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019;53(4):1802339.

    OpenUrlAbstract/FREE Full Text
11. 11.
    1. McGrath JA,
    2. O’Toole C,
    3. Bennett G,
    4. Joyce M,
    5. Byrne MA,
    6. MacLoughlin R

    . Investigation of fugitive aerosols released into the environment during high-flow therapy. Pharmaceutics 2019;11(6):254.

    OpenUrlCrossRefPubMed
12. 12.
    1. Avari H,
    2. Hiebert RJ,
    3. Ryzynski AA,
    4. Levy A,
    5. Nardi J,
    6. Kanji-Jaffer H,
    7. et al

    . Quantitative assessment of viral dispersion associated with respiratory support devices in a simulated critical care environment. Am J Respir Crit Care Med 2021;203(9):1112-1118.

    OpenUrl
13. 13.↵
    1. Kotoda M,
    2. Hishiyama S,
    3. Mitsui K,
    4. Tanikawa T,
    5. Morikawa S,
    6. Takamino A,
    7. et al

    . Assessment of the potential for pathogen dispersal during high-flow nasal therapy. J Hosp Infect 2020;104(4):534-537.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Iwashyna TJ,
    2. Boehman A,
    3. Capelcelatro J,
    4. Cohn AM,
    5. Cooke JM,
    6. Costa DK,
    7. et al

    . Variation in aerosol production across oxygen delivery devices in spontaneously breathing human subjects. MedRxiv 2020. doi: 10.1101/2020.04.15.20066688.
15. 15.↵
    1. Gaeckle NT,
    2. Lee J,
    3. Park Y,
    4. Kreykes G,
    5. Evans MD,
    6. Hogan CJ Jr.

    Aerosol generation from the respiratory tract with various modes of oxygen delivery. Am J Respir Crit Care Med 2020;202(8):1115-1124.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Leung CCH,
    2. Joynt GM,
    3. Gomersall CD,
    4. Wong WT,
    5. Lee A,
    6. Ling L,
    7. et al

    . Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. J Hosp Infect 2019;101(1):84-87.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Simonds AK,
    2. Hanak A,
    3. Chatwin M,
    4. Morrell M,
    5. Hall A,
    6. Parker KH,
    7. et al

    . Evaluation of droplet dispersion during noninvasive ventilation, oxygen therapy, nebulizer treatment, and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess 2010;14(46):131-172.

    OpenUrlPubMed
18. 18.↵
    1. Winslow RL,
    2. Zhou J,
    3. Windle EF,
    4. Nur I,
    5. Lall R,
    6. Ji C,
    7. et al

    . SARS-CoV-2 environmental contamination from hospitalized patients with COVID-19 receiving aerosol-generating procedures. Thorax 2022;77(3):259-267.

    OpenUrlAbstract/FREE Full Text
19. 19.
    1. Lebreil AL,
    2. Greux V,
    3. Glenet M,
    4. Huguenin A,
    5. N’Guyen Y,
    6. Berri F,
    7. et al

    . Surfaces and air contamination by severe acute respiratory syndrome coronavirus 2 using high-flow nasal oxygenation or assisted mechanical ventilation in intensive care unit rooms of patients with coronavirus disease 2019. J Infect Dis 2022;225(3):385-391.

    OpenUrl
20. 20.↵
    1. Roca O,
    2. Pacheco A,
    3. Rodon J,
    4. Anton A,
    5. Vergara-Alert J,
    6. Armadans L,
    7. et al

    . Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination. J Hosp Infect 2021;116:103-105.

    OpenUrl
21. 21.↵
    1. Cevik M,
    2. Tate M,
    3. Lloyd O,
    4. Maraolo AE,
    5. Schafers J,
    6. Ho A

    . SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe 2021;2(1):e13-e22.

    OpenUrl
22. 22.↵
    1. Popa A,
    2. Genger JW,
    3. Nicholson MD,
    4. Penz T,
    5. Schmid D,
    6. Aberle SW,
    7. et al

    . Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Transl Med 2020;12(573).